Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.R600004200 on April 28, 2006

J. Biol. Chem., Vol. 281, Issue 26, 17541-17544, June 30, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/26/17541    most recent
R600004200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Rock, C. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Rock, C. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Minireview

Inhibiting Bacterial Fatty Acid Synthesis*

Yong-Mei Zhang{ddagger}, Stephen W. White§, and Charles O. Rock{ddagger}1

From the Departments of {ddagger}Infectious Diseases and §Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794

The type II fatty acid synthase consists of a series of individual enzymes, each encoded by a separate gene, that catalyze discrete steps in chain elongation. The formation of fatty acids is vital to bacteria, and each of the essential enzymes and their acyl group carriers represent a potential target for the development of novel antibacterial therapeutics. High resolution x-ray and/or NMR structures of representative members of every enzyme in the type II pathway are now available, and these structures are a valuable resource to guide antibacterial drug discovery. The role of each enzyme in regulating pathway activity and the diversity in the components of the pathway in the major human pathogens are important considerations in deciding the most suitable targets for future drug development.


* This minireview will be reprinted in the 2006 Minireview Compendium, which will be available in January, 2007. This work was supported by National Institutes of Health Grant GM34496 (to C. O. R.), Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities.

1 To whom correspondence should be addressed: Dept. of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794. Tel.: 901-495-3491; Fax: 901-495-3099; E-mail: charles.rock{at}stjude.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
C. J. Zheng, M.-J. Sohn, and W.-G. Kim
Vinaxanthone, a new FabI inhibitor from Penicillium sp.
J. Antimicrob. Chemother., May 1, 2009; 63(5): 949 - 953.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
W.-Q. Song, Y.-M. Qin, M. Saito, T. Shirai, F. M. Pujol, A. J. Kastaniotis, J. K. Hiltunen, and Y.-X. Zhu
Characterization of two cotton cDNAs encoding trans-2-enoyl-CoA reductase reveals a putative novel NADPH-binding motif
J. Exp. Bot., April 1, 2009; 60(6): 1839 - 1848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. I. Chan, T. Stockner, D. P. Tieleman, and H. J. Vogel
Molecular Dynamics Simulations of the Apo-, Holo-, and Acyl-forms of Escherichia coli Acyl Carrier Protein
J. Biol. Chem., November 28, 2008; 283(48): 33620 - 33629.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Johansson, B. Wiltschi, P. Kumari, B. Kessler, C. Vonrhein, J. Vonck, D. Oesterhelt, and M. Grininger
Inhibition of the fungal fatty acid synthase type I multienzyme complex
PNAS, September 2, 2008; 105(35): 12803 - 12808.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y.-M. Zhang and C. O. Rock
Thematic Review Series: Glycerolipids. Acyltransferases in bacterial glycerophospholipid synthesis
J. Lipid Res., September 1, 2008; 49(9): 1867 - 1874.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Gratraud, N. Surolia, G. S. Besra, A. Surolia, and L. Kremer
Antimycobacterial Activity and Mechanism of Action of NAS-91
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1162 - 1166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Massengo-Tiasse and J. E. Cronan
Vibrio cholerae FabV Defines a New Class of Enoyl-Acyl Carrier Protein Reductase
J. Biol. Chem., January 18, 2008; 283(3): 1308 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Stephens, S. H. Lee, K. S. Paul, and P. T. Englund
Mitochondrial Fatty Acid Synthesis in Trypanosoma brucei
J. Biol. Chem., February 16, 2007; 282(7): 4427 - 4436.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement